Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Circulation Research|June 23, 2012
Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarctionEva Wagner, Marcel A Lauterbach, Tobias Kohl, et al.Proceedings of the National Academy of Sciences of the United States of America|October 2, 2015
STIM1-Ca2+ signaling modulates automaticity of the mouse sinoatrial nodeHengtao Zhang, Albert Y Sun, Jong J Kim, et al.Journal of Medicinal Chemistry|May 18, 2012
Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modelingHuifen Chen, Bryan K Chan, Jason Drummond, et al.Journal of Autoimmunity|February 21, 2021
Role of the thymus in spontaneous development of a multi-organ autoimmune disease in human immune system miceMohsen Khosravi-Maharlooei, HaoWei Li, Markus Hoelzl, et al.JCI Insight|October 28, 2021
Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stressUma Mahesh R Avula, Haikel Dridi, Bi-Xing Chen, et al.The Journal of Physiology|March 17, 2015
Deranged sodium to sudden deathColleen E Clancy, Ye Chen-Izu, Donald M Bers, et al.Journal of Medicinal Chemistry|August 20, 2016
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) InhibitorsMark Zak, Po-Wai Yuen, Xiongcai Liu, et al.Journal of Medicinal Chemistry|May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase InhibitorsCorinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT)Peter S Dragovich, Guiling Zhao, Timm Baumeister, et al.Circulation|November 14, 2007
Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel functionStephan E Lehnart, Michael J Ackerman, D Woodrow Benson, et al.Pageof 15